Published June 2017 | Version v1
Journal article Metadata-only

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

Creators

  • 1. Ludwig-Maximilians-University of Munich, Department of Nuclear Medicine, Munich (Germany)
  • 2. UCLA, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, Los Angeles, CA (United States)
  • 3. Technical University of Munich, Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich (Germany)
  • 4. St. Vincent's Hospital, Department of Nuclear Medicine and Endocrinology, PET-CT Center, Linz (Austria)
  • 5. UCL/UCLH, Institute of Nuclear Medicine, London (United Kingdom)
  • 6. University of Bologna, S. Orsola Hospital Bologna, Nuclear Medicine Unit, Bologna (Italy)
  • 7. University of Wisconsin School of Medicine and Public Health, Department of Radiology, Madison, WI (United States)
  • 8. University Hospital Heidelberg and DKFZ Heidelberg, Department of Nuclear Medicine, Heidelberg (Germany)
  • 9. University of California, Department of Radiology and Biomedical Imaging, San Francisco, CA (United States)
  • 10. German Cancer Research Center (DKFZ) Heidelberg, Division of Radiopharmaceutical Chemistry, Heidelberg (Germany)
  • 11. University Medical Center, University of Rostock, Department of Nuclear Medicine, Rostock (Germany)
  • 12. Maastricht University Medical Center (MUMC), Department of Nuclear Medicine, Maastricht (Netherlands)
  • 13. University Hospital RWTH Aachen University, Department of Nuclear Medicine, Aachen (Germany)
  • 14. Memorial Sloan-Kettering Cancer Center, New York, NY (United States)
  • 15. University of Iowa Hospitals and Clinics, Department of Radiology, Iowa City, IA (United States)
  • 16. Technische Universitaet Muenchen, Pharmaceutical Radiochemistry, Garching (Germany)
  • 17. Universitaetsklinikum Essen, Klinik fuer Nuklearmedizin, Essen (Germany)

Description

The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of 68Ga-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of 68Ga-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-017-3670-z

Additional details

Identifiers

DOI
10.1007/s00259-017-3670-z;

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
44
Journal Issue
6
Journal Page Range
p. 1014-1024
ISSN
1619-7070

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
48053322
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ACCURACY; ANTIGENS; BIOPSY; CARCINOMAS; COMPUTERIZED TOMOGRAPHY; GALLIUM 68; MEGA BQ RANGE 100-1000; METASTASES; MONITORING; NMR IMAGING; POSITRON COMPUTED TOMOGRAPHY; PROSTATE; RADIOPHARMACEUTICALS; RADIOTHERAPY; RECOMMENDATIONS; UPTAKE
Descriptors DEC
BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; GALLIUM ISOTOPES; GLANDS; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; ISOTOPES; LABELLED COMPOUNDS; MALE GENITALS; MATERIALS; MEDICINE; MEGA BQ RANGE; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOACTIVE MATERIALS; RADIOACTIVITY RANGE; RADIOISOTOPES; RADIOLOGY; THERAPY; TOMOGRAPHY